-
The systematic review by Péus (2022) evaluates the effectiveness of ear cryotherapy for protecting the inner ear from damage caused by various conditions. The analysis includes ten studies that explored the therapy’s impact on hearing and balance preservation. Across these studies, significant otoprotective benefits were observed, indicating that ear cryotherapy could be a viable approach to mitigating inner ear damage in conditions like noise-induced hearing loss, ototoxicity, and ischemic injury. The review highlights how the therapy works to stabilize inner ear function and preserve sensory cells, demonstrating consistent positive outcomes.
Looking forward, the review emphasizes the need for more extensive clinical trials to validate the potential of ear cryotherapy. While the initial findings are promising, more research is necessary to refine treatment protocols and expand the understanding of its effectiveness across different patient populations.
-
Cool OtOprotective Ear Lumen (COOL) Therapy for Cisplatin-induced Hearing Loss (Stanford, 2021)
The study “Cool Otoprotective Ear Lumen (COOL) Therapy for Cisplatin-induced Hearing Loss” by Stanford (2021) investigates the efficacy of localized cooling of the ear canal in reducing hearing loss caused by cisplatin, a chemotherapy drug known for its ototoxic effects. In this study, guinea pigs subjected to cisplatin treatments received localized cooling interventions, such as cool water irrigation and the use of an ear bar. The results showed a significant reduction in hearing loss and hair cell damage in the inner ear, suggesting that cooling the ear canal offers protective benefits without diminishing the cancer-fighting effectiveness of cisplatin.
This study is significant because it highlights a potential non-invasive strategy to prevent one of the most challenging side effects of cisplatin therapy. The findings indicate that localized cooling can serve as an otoprotective method, potentially preserving hearing in patients undergoing cisplatin treatment without interfering with its primary purpose—destroying cancer cells. The research suggests that further development of cooling devices and techniques could lead to widely accessible clinical interventions that offer both ease of use and high efficacy, providing patients with much-needed protection against drug-induced hearing damage.
-
The review “Cooling the Cochlea: Slowing Down Metabolism May Be a Way of Protecting Hearing from Surgical Trauma” by Bell (2023) examines how body temperature influences extended high-frequency (EHF) hearing, which includes frequencies beyond 8 kHz. These higher frequencies are particularly vulnerable to noise-induced hearing loss and are critical for early detection of auditory damage. The review highlights that lower body and cochlear temperatures are associated with neuroprotective effects, as they appear to reduce metabolic activity in the cochlea, thereby protecting delicate hair cells from trauma and noise exposure.
The review suggests that reducing metabolic demands through cooling could be an effective way to preserve EHF hearing during surgical procedures or in environments with high noise levels. Cooling interventions may help stabilize the cochlea’s environment, potentially minimizing cellular stress and damage, which are common contributors to high-frequency hearing loss.